Provides gentle, label-free cell enrichment using levitation technology for high-quality sample preparation in advanced research applications.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
LevitasBio provides innovative cell processing solutions using proprietary levitation technology to enable gentle, label-free enrichment and analysis of viable cells. Their platforms streamline sample preparation for applications such as single-cell genomics, cancer profiling, and 3D cell culture, helping researchers obtain high-quality, debris-free cells for downstream analysis.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
LevitasBio Management Team
Investors
Decheng Capital LLC
Novalis LifeSciences LLC
Pavilion Capital
Thalys Medical Technology Group Inc.
LevitasBio Valuations & Financials
View real-time NPM data on LevitasBio stock including daily LevitasBio stock price estimates, valuation history, and historical share price information. Access LevitasBio financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track LevitasBio pricing across six independent market signals. Looking for private company due diligence data sources on LevitasBio? Get in touch to learn more.
Similar Companies
like LevitasBio
Podium
Enterprise Software
Customer messaging platform enabling companies to connect at critical touch points.
Attovia
Healthcare & Life Sciences
Pipeline of bio-therapeutics with an initial focus on immune-mediated diseases.
Physna
Enterprise Software
Develops geometric search software that enables efficient 3D model comparison and analysis for optimizing product design processes.
HydroPoint
Industrials
Optimize water usage that tunes irrigation, tracks leaks, and provides unified visibility across indoor and outdoor systems.
MaintainX
Enterprise Software
Provides a mobile-first Frontline Record Management (FRM) platform.
Section
Consumer
Delivers hands-on AI training and learning solutions to help professionals integrate artificial intelligence into their work processes.
Scribe
Healthcare & Life Sciences
Focused on the development of CRISPR molecules to rewrite and repair the underlying cause of genetic disorders.
Dalia
AI & Machine Learning
Analyzes wearable sensor data to monitor physiological signals and support digital health insights.
FAQ
We have answers
LevitasBio stock does not trade on public stock exchanges. LevitasBio stock is considered a private security and you need to be an accredited investor to trade shares. To invest in LevitasBio stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
LevitasBio Stock does not trade on public stock exchanges. In order to sell LevitasBio shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
LevitasBio does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view LevitasBio share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for LevitasBio stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell LevitasBio stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in LevitasBio stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
LevitasBio is a private company and has not had an IPO. There is currently no LevitasBio IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to LevitasBio IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
